Abiomed Inc (NASDAQ:ABMD)

268.45
Delayed Data
As of Feb 23
 +4.48 / +1.70%
Today’s Change
114.28
Today|||52-Week Range
274.00
+43.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues124.7M132.5M132.8M154.0M
 
 
 
 
 
Cost of Goods Sold17.5M19.4M18.8M22.2M
 
 
 
 
 
Depreciation And Amortization1.7M2.5M2.9M2.8M
 
 
 
 
 
 
Operating ExpensesGross Income105.4M110.6M111.2M129.0M
 
 
 
 
 
General Expenses76.4M77.3M79.1M83.7M
 
 
 
 
 
Research And Development16.3M16.7M19.0M17.1M
 
 
 
 
 
Total Operating Expenses95.7M99.1M100.7M108.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income29.0M33.3M32.1M45.4M
 
 
 
 
 
Extraordinary Charge0.00-265.0K-417.0K-588.0K
 
 
 
 
Other Expenses-124.0K79.0K-23.0K-81.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income29.4M33.8M32.5M45.7M
 
 
 
 
 
Income Taxes-14.5M-3.6M-8.0M-32.2M
 
 
 
 
 
Net Income14.9M37.4M24.5M13.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.6M43.9M44.1M44.2M
 
 
 
 
 
Shares To Calculate EPS Diluted44.9M45.6M45.7M45.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.33$0.82$0.54$0.29
 
 
 
 
 
EPS Diluted$0.33$0.82$0.54$0.29